Literature DB >> 18216355

HLA-mismatched renal transplantation without maintenance immunosuppression.

Tatsuo Kawai1, A Benedict Cosimi, Thomas R Spitzer, Nina Tolkoff-Rubin, Manikkam Suthanthiran, Susan L Saidman, Juanita Shaffer, Frederic I Preffer, Ruchuang Ding, Vijay Sharma, Jay A Fishman, Bimalangshu Dey, Dicken S C Ko, Martin Hertl, Nelson B Goes, Waichi Wong, Winfred W Williams, Robert B Colvin, Megan Sykes, David H Sachs.   

Abstract

Five patients with end-stage renal disease received combined bone marrow and kidney transplants from HLA single-haplotype mismatched living related donors, with the use of a nonmyeloablative preparative regimen. Transient chimerism and reversible capillary leak syndrome developed in all recipients. Irreversible humoral rejection occurred in one patient. In the other four recipients, it was possible to discontinue all immunosuppressive therapy 9 to 14 months after the transplantation, and renal function has remained stable for 2.0 to 5.3 years since transplantation. The T cells from these four recipients, tested in vitro, showed donor-specific unresponsiveness and in specimens from allograft biopsies, obtained after withdrawal of immunosuppressive therapy, there were high levels of P3 (FOXP3) messenger RNA (mRNA) but not granzyme B mRNA. Copyright 2008 Massachusetts Medical Society.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216355      PMCID: PMC2819046          DOI: 10.1056/NEJMoa071074

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  28 in total

1.  Why do we reject a graft? Role of indirect allorecognition in graft rejection.

Authors:  M H Sayegh
Journal:  Kidney Int       Date:  1999-11       Impact factor: 10.612

Review 2.  Engraftment syndrome following hematopoietic stem cell transplantation.

Authors:  T R Spitzer
Journal:  Bone Marrow Transplant       Date:  2001-05       Impact factor: 5.483

Review 3.  Strategies to improve long-term outcomes after renal transplantation.

Authors:  Manuel Pascual; Tom Theruvath; Tatsuo Kawai; Nina Tolkoff-Rubin; A Benedict Cosimi
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

4.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

5.  Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses.

Authors:  Y Fudaba; T R Spitzer; J Shaffer; T Kawai; T Fehr; F Delmonico; F Preffer; N Tolkoff-Rubin; B R Dey; S L Saidman; A Kraus; T Bonnefoix; S McAfee; K Power; K Kattleman; R B Colvin; D H Sachs; A B Cosimi; M Sykes
Journal:  Am J Transplant       Date:  2006-06-22       Impact factor: 8.086

6.  Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease.

Authors:  Leo H Bühler; Thomas R Spitzer; Megan Sykes; David H Sachs; Francis L Delmonico; Nina Tolkoff-Rubin; Susan L Saidman; Robert Sackstein; Steven McAfee; Bimalangshu Dey; Christine Colby; A Benedict Cosimi
Journal:  Transplantation       Date:  2002-11-27       Impact factor: 4.939

7.  Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance.

Authors:  T Kawai; A Poncelet; D H Sachs; S Mauiyyedi; S Boskovic; S L Wee; D S Ko; A Bartholomew; M Kimikawa; H Z Hong; G Abrahamian; R B Colvin; A B Cosimi
Journal:  Transplantation       Date:  1999-12-15       Impact factor: 4.939

8.  Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation.

Authors:  Maria T Millan; Judith A Shizuru; Petra Hoffmann; Sussan Dejbakhsh-Jones; John D Scandling; F Carl Grumet; Jane C Tan; Oscar Salvatierra; Richard T Hoppe; Samuel Strober
Journal:  Transplantation       Date:  2002-05-15       Impact factor: 4.939

9.  Mixed chimerism and tolerance without whole body irradiation in a large animal model.

Authors:  Y Fuchimoto; C A Huang; K Yamada; A Shimizu; H Kitamura; R B Colvin; V Ferrara; M C Murphy; M Sykes; M White-Scharf; D M Neville; D H Sachs
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

10.  Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients.

Authors:  Gaetano Ciancio; George W Burke; Rolando Garcia-Morales; Kiliana Suzart; Anne Rosen; Camillo Ricordi; Norma S Kenyon; James M Mathew; Andreas G Tzakis; Violet Esquenazi; Joshua Miller
Journal:  Transplantation       Date:  2002-08-27       Impact factor: 4.939

View more
  391 in total

Review 1.  Why some organ allografts are tolerated better than others: new insights for an old question.

Authors:  Travis D Hull; Gilles Benichou; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2019-02       Impact factor: 2.640

2.  Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates.

Authors:  Y Yamada; T Ochiai; S Boskovic; O Nadazdin; T Oura; D Schoenfeld; K Cappetta; R-N Smith; R B Colvin; J C Madsen; D H Sachs; G Benichou; A B Cosimi; T Kawai
Journal:  Am J Transplant       Date:  2014-11-13       Impact factor: 8.086

3.  The role of natural killer T cells in costimulation blockade-based mixed chimerism.

Authors:  Patrick-Nikolaus Nierlich; Christoph Klaus; Sinda Bigenzahn; Nina Pilat; Zvonimir Koporc; Ines Pree; Ulrike Baranyi; Masaru Taniguchi; Ferdinand Muehlbacher; Thomas Wekerle
Journal:  Transpl Int       Date:  2010-11       Impact factor: 3.782

4.  Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants.

Authors:  J D Scandling; S Busque; S Dejbakhsh-Jones; C Benike; M Sarwal; M T Millan; J A Shizuru; R Lowsky; E G Engleman; S Strober
Journal:  Am J Transplant       Date:  2012-03-08       Impact factor: 8.086

Review 5.  CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.

Authors:  Qizhi Tang; Jeffrey A Bluestone; Sang-Mo Kang
Journal:  J Mol Cell Biol       Date:  2011-12-14       Impact factor: 6.216

Review 6.  Learning to live together: harnessing regulatory T cells to induce organ transplant tolerance.

Authors:  Andrew Y Chang; Nupur Bhattacharya
Journal:  Yale J Biol Med       Date:  2011-12

7.  An act of tolerance.

Authors:  Elie Dolgin
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

Review 8.  Immune monitoring as prerequisite for transplantation tolerance trials.

Authors:  K Behnam Sani; B Sawitzki
Journal:  Clin Exp Immunol       Date:  2017-06-23       Impact factor: 4.330

9.  Increased levels of anti-non-Gal IgG following pig-to-baboon bone marrow transplantation correlate with failure of engraftment.

Authors:  Fan Liang; Isaac Wamala; Joseph Scalea; Aseda Tena; Taylor Cormack; Shannon Pratts; Raimon Duran-Struuck; Nahel Elias; Martin Hertl; Christene A Huang; David H Sachs
Journal:  Xenotransplantation       Date:  2013-10-29       Impact factor: 3.907

Review 10.  Mouse models in bone marrow transplantation and adoptive cellular therapy.

Authors:  Caroline Arber; Malcolm K Brenner; Pavan Reddy
Journal:  Semin Hematol       Date:  2013-06-11       Impact factor: 3.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.